Global Platform Study Presents Results To Guide Care Of Severely Ill COVID-19 Patients Using Routinely Available Drugs

The world’s largest trial of multiple interventions for critically ill adults with COVID-19 has simultaneously released results about two of its treatments, vitamin C and simvastatin.   Published today in JAMA and NEJM, and presented at ...

Related Keywords

Belfast ,United Kingdom ,New Zealand ,Milan ,Lombardia ,Italy ,Danny Mcauley ,Neill Adhikari ,World Health Organization ,Research Institute Of New Zealand On Infopages ,Queen University Belfast ,Research Institute Of New Zealand ,Multifactorial Adaptive Platform For Community Acquired Pneumonia ,European Society Of Intensive Care Medicine ,Using Routinely Available Drugsthursday ,Medical Research Institute ,European Society ,Intensive Care Medicine ,Community Acquired Pneumonia ,Royal Victoria Hospital ,University Belfast ,Simvastatin Domain ,Vitaminc Domain ,Aotearoa New Zealand ,Intensive Care Units ,Edical Research Institute Of New Zealand ,Health ,Healthcare Industry ,Medical ,Ewsworthy ,Primary Health ,Science ,Orld News ,Scoop ,